RAM
BIIB icon

Roanoke Asset Management’s Biogen BIIB Stock Holding History

Roanoke Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-5,025
Closed -$1.37M – 106
2017
Q1 		$1.37M Sell
5,025
-1,235
-20% -$349K 0.65% 51
2016
Q4 		$1.77M Hold
6,260
– – 0.81% 48
2016
Q3 		$1.96M Sell
6,260
-370
-6% -$110K 0.89% 44
2016
Q2 		$1.6M Sell
6,630
-20
-0.3% -$5.27K 0.74% 47
2016
Q1 		$1.73M Buy
6,650
+50
+0.8% +$13.2K 0.8% 43
2015
Q4 		$2.02M Sell
6,600
-1,300
-16% -$374K 0.87% 42
2015
Q3 		$2.31M Buy
+7,900
New +$2.61M 0.85% 44

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Roanoke Asset Management's BIIB Position: Q2 2017 in Review

Roanoke Asset Management sold out of Biogen (BIIB) in Q2 2017, closing a stake of 5,025 shares — an estimated $1.37M sold.

Roanoke Asset Management first reported a position in BIIB in Q3 2015 and held it in 7 quarters. The position peaked at $2.31M in Q3 2015. 993 funds tracked by Wall St. Rank hold BIIB as of Q2 2017.

  • Roanoke Asset Management reported no remaining Biogen position as of Q2 2017 after selling out during the quarter.
  • Roanoke Asset Management sold 5,025 Biogen shares in Q2 2017, an estimated $1.37M.
  • Roanoke Asset Management first reported a position in Biogen in Q3 2015 and held it in 7 quarters.
  • Roanoke Asset Management's Biogen position peaked at $2.31M in Q3 2015.
  • 993 funds tracked by Wall St. Rank held Biogen as of Q2 2017.

Based on Roanoke Asset Management's 13F filing for Q2 2017, filed 19 Jul 2017.